Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Session 3: Fu-Wen Chang, nternational Federation of Pharmaceutical Wholesalers (IFPW) / Implemention of Good Practices for Safe Medicines

2,288 views

Published on

IFPMA-TFDA Workshop on Couterfeit Medicines
‘Integrated Approach Against Fake Medicines’
Session 3: Practices and Technologies for Prevention, Detection, Control and Monitoring of Fake Medicines

On 6th February 2015
At Taipei International Convention Center
Taipei, Taiwan

Published in: Health & Medicine
  • Login to see the comments

Session 3: Fu-Wen Chang, nternational Federation of Pharmaceutical Wholesalers (IFPW) / Implemention of Good Practices for Safe Medicines

  1. 1. © Zuellig Pharma. All Rights Reserved. BY Fu-Wen Chang / Senior QA Manager 2015-02-06
  2. 2. © Zuellig Pharma. All Rights Reserved. • Pharmaceutical Distribution Model • Introduction of Zuellig Pharma Inc. • Practices of Counterfeiting Product Handling • Challenges 2
  3. 3. © Zuellig Pharma. All Rights Reserved. To understand • how Zuellig Pharma to prevent the counterfeited products from entering into supply chain. • how to effective handling of counterfeited products found through the distribution and warehousing cycle. 3
  4. 4. © Zuellig Pharma. All Rights Reserved. 4 Manufacturer Road Transport Air Transit Road Transport Dispatch Customers Pharmacy Hospital Pharmaceutical Distribution Model Distribution Center Wholesaler
  5. 5. © Zuellig Pharma. All Rights Reserved. 5 Introduction of Zuellig Pharma Inc. Zuellig Pharma Inc. Taiwan Distribution Center • PIC/S GMP certified • GDP rewarded
  6. 6. © Zuellig Pharma. All Rights Reserved. 6 Introduction of Zuellig Pharma Inc.
  7. 7. © Zuellig Pharma. All Rights Reserved. 7 Introduction of Zuellig Pharma Inc. Key Figures Sales Channels • Established 1988(DC in 2005). • Annual Sales of around 1.3 bio USD • 500+ employees • Single Distribution Center • 3 offices • Representing over 30 International Manufacturers • Around 51% Market Share of Multinational Pharmaceutical products in Taiwan • Largest promoter in the DS/GP channels with over 100 sales representatives Number of Customers % Hospital / HP 532 100% Clinic / GP 7,946 84% Pharmacy / DS 7,367 85% TOTAL 15,845 85% Note: In terms of value, coverage exceeds 96% of Total Market Value
  8. 8. © Zuellig Pharma. All Rights Reserved. 8 Manufacturer Road Transport Air Transit Road Transport Dispatch Practices of Counterfeiting Product Handling Distribution Center Wholesaler Customers Pharmacy Hospital
  9. 9. © Zuellig Pharma. All Rights Reserved. 9 Manufacturer Road Transport Air Transit Road Transport Practices of Counterfeiting Product Handling INBOUND: Receiving •Accept finished goods only from Principal- authorized Personnel and forwarders with corresponding delivery documents. Distribution Center Wholesaler
  10. 10. © Zuellig Pharma. All Rights Reserved. 10 Manufacturer Road Transport Air Transit Road Transport INBOUND: Receiving •Goods receipts from forwarder shall be taken sampling or QA check by principal if required. This checking process will ensure that the products received are genuine. Distribution Center Wholesaler Practices of Counterfeiting Product Handling
  11. 11. © Zuellig Pharma. All Rights Reserved. 11 Dispatch INBOUND: Returned •Goods returned from customers must be checked against the lot number which can be traced back to the legitimate source. Distribution Center Wholesaler Customers Pharmacy Hospital Practices of Counterfeiting Product Handling
  12. 12. © Zuellig Pharma. All Rights Reserved. 12 Dispatch INBOUND: Returned Counterfeit products can usually be identified by: •Poor packaging/paper quality •Anti-fraud label (if any) •Color •Blister layout (if applicable) •Color of the content (such as table, capsules, etc) •Purity of the color of the content •Labeling & leaflet Distribution Center Wholesaler Customers Pharmacy Hospital Practices of Counterfeiting Product Handling
  13. 13. © Zuellig Pharma. All Rights Reserved. 13 STORAGE & REPACAKGE •Alert principals immediately of any incident where stocks may have been lost or stolen. •Samples, rejected product, rejected packaging components shall be disposed of in accordance with established procedures so that unauthorized use or diversion is not possible. •Used product containers or cartons shall be defaced or torn prior to disposal. Practices of Counterfeiting Product Handling
  14. 14. © Zuellig Pharma. All Rights Reserved. 14 REDRESSING •Excess Principal-supplied packaging components, stickers, and/or promotional items in the repacking section shall be controlled, monitored, recorded and locked. The details and quantity shall be coordinated with the Principals concerned for proper disposal in accordance with established procedures. Practices of Counterfeiting Product Handling
  15. 15. © Zuellig Pharma. All Rights Reserved. 15 Dispatch OUTBOUND •Deliver stocks only to licensed and authorized customers, distributors, hospitals and pharmacies. •Products are secured during whole delivery. •Delivery route monitoring by GPS. •DRS ensures all deliveries are tracking. Distribution Center Wholesaler Customers Pharmacy Hospital Practices of Counterfeiting Product Handling
  16. 16. © Zuellig Pharma. All Rights Reserved. 16 Manufacturer Road Transport Air Transit Road Transport Dispatch Any confirmed or suspected counterfeited product found during stock in/out, must be immediately communicated to the principal for further investigation and prompt action. Distribution Center Wholesaler Customers Pharmacy Hospital Practices of Counterfeiting Product Handling
  17. 17. © Zuellig Pharma. All Rights Reserved. 17 Manufacturer Road Transport Air Transit Road Transport Dispatch Zuellig Management and the concerned Principal shall be notified immediately of incidents where counterfeiting or illegal trading is suspected. Distribution Center Wholesaler Customers Pharmacy Hospital Practices of Counterfeiting Product Handling
  18. 18. © Zuellig Pharma. All Rights Reserved. 18 Manufacturer Road Transport Air Transit Road Transport Dispatch Any counterfeited products found in the supply chain will immediately be physically segregated and stored in a dedicated area away from all other medicinal products and be appropriately labelled. Distribution Center Wholesaler Customers Pharmacy Hospital Practices of Counterfeiting Product Handling
  19. 19. © Zuellig Pharma. All Rights Reserved. 19 Dispatch Challenges Distribution Center Wholesaler Secondary Wholesaler Middlemen Customers Pharmacy Hospital Customers GDP controlled Not controlled
  20. 20. © Zuellig Pharma. All Rights Reserved. 20

×